These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7662893)

  • 21. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal cyclin-dependent kinase 5 activity is critical for survival.
    Tanaka T; Veeranna ; Ohshima T; Rajan P; Amin ND; Cho A; Sreenath T; Pant HC; Brady RO; Kulkarni AB
    J Neurosci; 2001 Jan; 21(2):550-8. PubMed ID: 11160434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality.
    Chae T; Kwon YT; Bronson R; Dikkes P; Li E; Tsai LH
    Neuron; 1997 Jan; 18(1):29-42. PubMed ID: 9010203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens.
    Gao CY; Zakeri Z; Zhu Y; He H; Zelenka PS
    Dev Genet; 1997; 20(3):267-75. PubMed ID: 9216066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
    Shelton SB; Krishnamurthy P; Johnson GV
    J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdk5 interacts with Hif-1α in neurons: a new hypoxic signalling mechanism?
    Antoniou X; Gassmann M; Ogunshola OO
    Brain Res; 2011 Mar; 1381():1-10. PubMed ID: 20977891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain.
    Lee KY; Rosales JL; Tang D; Wang JH
    J Biol Chem; 1996 Jan; 271(3):1538-43. PubMed ID: 8576150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.
    Hosokawa T; Saito T; Asada A; Ohshima T; Itakura M; Takahashi M; Fukunaga K; Hisanaga S
    J Neurosci Res; 2006 Sep; 84(4):747-54. PubMed ID: 16802322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin-dependent protein kinase 5 activity increases in rat brain following ischemia.
    Green SL; Kulp KS; Vulliet R
    Neurochem Int; 1997 Oct; 31(4):617-23. PubMed ID: 9308012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a human cDNA encoding a kinase-defective cdk5 isoform.
    Moorthamer M; Zumstein-Mecker S; Stephan C; Mittl P; Chaudhuri B
    Biochem Biophys Res Commun; 1998 Dec; 253(2):305-10. PubMed ID: 9878533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porcine brain neurofilament-H tail domain kinase: its identification as cdk5/p26 complex and comparison with cdc2/cyclin B kinase.
    Hisanaga S; Uchiyama M; Hosoi T; Yamada K; Honma N; Ishiguro K; Uchida T; Dahl D; Ohsumi K; Kishimoto T
    Cell Motil Cytoskeleton; 1995; 31(4):283-97. PubMed ID: 7553915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of proteins regulating cell cycle progression in growth vs. differentiation.
    Li Z; Hromchak R; Bloch A
    Biochim Biophys Acta; 1997 Apr; 1356(2):149-59. PubMed ID: 9150273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
    He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
    Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
    Lee MH; Nikolic M; Baptista CA; Lai E; Tsai LH; Massagué J
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3259-63. PubMed ID: 8622924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5.
    Shetty KT; Kaech S; Link WT; Jaffe H; Flores CM; Wray S; Pant HC; Beushausen S
    J Neurochem; 1995 May; 64(5):1988-95. PubMed ID: 7536802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in cyclin-dependent protein kinase 5 (CDK5) protein levels, activity and immunocytochemistry in canine motor neuron disease.
    Green SL; Vulliet PR; Pinter MJ; Cork LC
    J Neuropathol Exp Neurol; 1998 Nov; 57(11):1070-7. PubMed ID: 9825944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death.
    Ahuja HS; Zhu Y; Zakeri Z
    Dev Genet; 1997; 21(4):258-67. PubMed ID: 9438340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35.
    Amin ND; Albers W; Pant HC
    J Neurosci Res; 2002 Feb; 67(3):354-62. PubMed ID: 11813240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.
    Hosokawa Y; Yang M; Kaneko S; Tanaka M; Nakashima K
    Biochem Mol Biol Int; 1995 Oct; 37(2):393-9. PubMed ID: 8673024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.